BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 38513273)

  • 1. Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers.
    Niu S; Lucas E; Molberg K; Strickland A; Wang Y; Carrick K; Rivera-Colon G; Gwin K; SoRelle JA; Castrillon DH; Zheng W; Chen H
    Am J Surg Pathol; 2022 Oct; 46(10):1447-1455. PubMed ID: 35834400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morules and morule-like features associated with carcinomas in various organs: report with immunohistochemical and molecular studies.
    Makishi S; Kinjo T; Sawada S; Chinen K; Hirayasu T; Hamada T; Saito K; Iwamasa T
    J Clin Pathol; 2006 Jan; 59(1):95-100. PubMed ID: 16394288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules).
    Brachtel EF; Sánchez-Estevez C; Moreno-Bueno G; Prat J; Palacios J; Oliva E
    Am J Surg Pathol; 2005 Oct; 29(10):1322-9. PubMed ID: 16160475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2.
    Houghton O; Connolly LE; McCluggage WG
    Histopathology; 2008 Aug; 53(2):156-65. PubMed ID: 18752499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shadow cell differentiation from squamoid morule in endometrial adenoacanthoma.
    Nakamura T
    Int J Clin Exp Pathol; 2015; 8(10):13120-4. PubMed ID: 26722510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma.
    Raffone A; Travaglino A; Raimondo D; Boccellino MP; Maletta M; Borghese G; Casadio P; Insabato L; Mollo A; Zullo F; Seracchioli R
    Gynecol Oncol; 2021 May; 161(2):621-628. PubMed ID: 33715893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morules and β-catenin predict POLE mutation status in endometrial cancer: A pathway to more cost-effective diagnostic procedures.
    Fan R; Lin W; Zhao R; Li L; Xin R; Zhang Y; Liu Y; Ma Y; Wang Y; Wang Y; Zheng W
    Am J Clin Pathol; 2024 Mar; ():. PubMed ID: 38513273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular classification of endometrial carcinoma-a short summary for clinical use].
    Hiller GGR; Höhn AK; Mayr D; Brambs CE; Horn LC
    Pathologie (Heidelb); 2023 Nov; 44(6):392-400. PubMed ID: 37815668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POLE, MMR, and MSI Testing in Endometrial Cancer: Proceedings of the ISGyP Companion Society Session at the USCAP 2020 Annual Meeting.
    Casey L; Singh N
    Int J Gynecol Pathol; 2021 Jan; 40(1):5-16. PubMed ID: 33290350
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.